Home

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)

9.8900
-0.5600 (-5.36%)
NYSE · Last Trade: Apr 4th, 8:02 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)

Johnson & Johnson JNJ -4.12%

Competing in the realm of consumer health and personal care, Haleon and Johnson & Johnson share overlapping product lines, particularly in OTC medicines and skincare products. Johnson & Johnson's well-known brand portfolio and its strong R&D capabilities often enhance its competitive position, allowing it to innovate and meet consumer needs effectively. Haleon, although newer as a separate entity, is focused on prioritizing consumer health and enhancing its product lines, aiming to capitalize on shifting consumer preferences towards health-focused products. However, Johnson & Johnson typically maintains a competitive advantage due to its deep market penetration and comprehensive product offerings.

Pfizer Inc. PFE -5.43%

While Pfizer is traditionally known for its pharmaceuticals, it also competes with Haleon in the consumer healthcare space, especially with products that overlap into OTC medications and health-related consumer products. Pfizer’s extensive experience in drug development allows it to integrate more science-backed claims into its consumer health products. Haleon, with its specialized focus on consumer healthcare through its spin-off, is vying for market share in similar categories but often lags behind Pfizer’s credibility and recognition in health-focused areas, giving Pfizer a competitive edge.

Procter & Gamble Co. PG -5.01%

Haleon competes with Procter & Gamble in the personal health and wellness sector, with both companies offering a range of products that include vitamins, supplements, and oral healthcare items. P&G has a strong global presence, extensive marketing capabilities, and a broad array of trusted brands. Despite Haleon's focus on consumer health products, P&G's size and brand recognition often give it a competitive advantage in terms of distribution and consumer loyalty, particularly in established markets.

Reckitt Benckiser Group plc

Haleon plc and Reckitt Benckiser both operate in the consumer healthcare sector, focusing on over-the-counter (OTC) medicines, oral care, and wellness products. They compete primarily in product innovation, brand strength, and distribution networks, with Reckitt leveraging its extensive brand portfolio and market presence to maintain a competitive edge. Haleon, formed from the spin-off of GSK's consumer health business, is still establishing its brands and market positioning but focuses on products that prioritize health and wellness trends. As such, Reckitt Benckiser maintains a competitive advantage through its established reputation and diverse product offerings.